Highbridge Capital Management
New York City, New Yorkhighbridge.com
Overview
Highbridge Capital Management is a global alternative investment firm offering credit and volatility focused solutions across a range of liquidity and investment profiles, including hedge funds, drawdown vehicles and co-investments.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BIOR Biotech | Mar 2025 | Corporate Funding | Co-investor |
| Biora Therapeutics | Feb 2025 | Bankruptcy | Co-investor |
| Biocartis | Nov 2023 | Recap | Co-investor |
| Invacare Corporation | May 2023 | Debt | Co-investor |
| Invacare Corporation | May 2023 | Convertible Debt | Co-investor |
Key People
Christopher Hayward
Managing Partner
Andreas Schlotter
Managing Director
Julie Parker
Managing Director
Rich Potapchuk
Managing Director
Steve Ardovini
Managing Director
Vikas Keswani
Managing Director, Head Of Specialty Direct Lending North America
Jason Hempel
Co-CIO, Co-Portfolio Manager
Alain Sunier
Portfolio Manager
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
